Retour sur lavenir.net
   ARGENX SE 759.600 € (-0,55 %)     VGP 81.200 € (-0,25 %)     PROXIMUS 6.190 € (+4,47 %)     SYENSQO 67.550 € (+2,35 %)     FAGRON 24.000 € (+1,05 %)     ACKERMANS V.HAAREN 267.600 € (-0,15 %)     AB INBEV 69.640 € (-0,03 %)     SHURGARD 26.000 € (-1,14 %)     VASTNED 29.850 € (+1,53 %)     VIOHALCO 17.740 € (-0,34 %)     XIOR 27.700 € (+1,09 %)     BREDERODE 103.200 € (-0,19 %)     LOTUS BAKERIES 11 000.000 € (-1,96 %)     ORANGE BELGIUM 21.500 € (0,00 %)     BEKAERT 40.500 € (+1,50 %)     DECEUNINCK 2.220 € (-0,67 %)     TINC 11.300 € (+0,18 %)     AZELIS GROUP 10.410 € (+1,66 %)     ENERGYVISION 14.980 € (+0,54 %)     UCB 235.600 € (-0,63 %)     RETAIL ESTATES 68.800 € (+0,88 %)     WDP 21.800 € (-0,09 %)     WHAT'S COOKING GP 141.000 € (-1,40 %)     ONWARD MEDICAL 2.530 € (+0,80 %)     GIMV 45.500 € (+1,56 %)     HOME INVEST BE. 18.980 € (+0,21 %)     NYXOAH 1.492 € (-1,58 %)     ELIA GROUP 138.700 € (+1,46 %)     QRF 10.050 € (-0,99 %)     JENSEN-GROUP 81.200 € (-0,49 %)     AEDIFICA 68.850 € (-0,51 %)     BIOTALYS 3.005 € (-0,66 %)     SIPEF 90.200 € (-0,33 %)     AGEAS 70.950 € (+0,28 %)     BPOST 1.610 € (+1,26 %)     TITAN S.A. 50.200 € (-0,69 %)     SOLVAY 26.420 € (+1,30 %)     NEXTENSA 46.200 € (-1,70 %)     GBL 77.850 € (+0,13 %)     CMB.TECH 13.620 € (+1,49 %)     DEME GROUP 168.000 € (-0,36 %)     IMMOBEL 22.100 € (+0,45 %)     ASCENCIO 51.700 € (+0,58 %)     SOFINA 227.600 € (+0,53 %)     COLRUYT 37.180 € (+0,81 %)     FLUXYS BELGIUM D 19.500 € (-0,51 %)     CIE BOIS SAUVAGE 303.000 € (0,00 %)     WERELDHAVE BELGIUM 52.400 € (-0,76 %)     RECTICEL 11.780 € (+3,15 %)     UMICORE 20.440 € (+1,89 %)     D'IETEREN GROUP 171.400 € (-0,87 %)     MELEXIS 75.550 € (+4,50 %)     ONTEX GROUP 2.170 € (-1,81 %)     IBA 17.140 € (+3,00 %)     TUBIZE-FIN 206.000 € (-1,25 %)     CELYAD ONCOLOGY 0.246 € (+10,81 %)     AGFA-GEVAERT 0.414 € (+0,49 %)     KBC ANCORA 84.600 € (+0,36 %)     CARE PROPERTY INV. 12.620 € (+0,16 %)     OXURION 0.003 € (-6,67 %)  
   ORANGE 16.270 € (+2,52 %)     SHELL PLC 36.505 € (+2,18 %)     RENAULT 26.180 € (+1,43 %)     CSG 13.232 € (-2,72 %)     ACCOR 48.030 € (-1,96 %)     TOTALENERGIES 70.420 € (+2,98 %)     ASM INTERNATIONAL 889.600 € (-2,28 %)     PERNOD RICARD 64.220 € (+0,03 %)     ASML HOLDING 1 540.800 € (-1,80 %)     CEGEDIM 10.240 € (-2,10 %)     CREDIT AGRICOLE 17.550 € (+0,34 %)     2CRSI 29.500 € (-3,91 %)     SANOFI 77.100 € (+1,14 %)     ADP 111.400 € (-0,18 %)     MICHELIN 34.730 € (-0,40 %)     AXA 44.320 € (+0,11 %)     WERELDHAVE 19.040 € (-0,83 %)     ALLFUNDS GROUP 8.640 € (+0,35 %)     UMG 19.140 € (+1,22 %)     UNILEVER 53.800 € (-0,39 %)     ATOS GROUP 33.000 € (-0,48 %)     ING GROEP N.V. 28.420 € (+0,02 %)     INTRASENSE 0.232 € (-2,52 %)     MAGNUM 16.262 € (-0,28 %)     WORLDLINE 9.622 € (-5,89 %)     CARREFOUR 16.615 € (+0,76 %)     VALEO 12.510 € (+0,93 %)     CLARIANE 4.020 € (+1,26 %)     MEXEDIA 3.500 € (-3,58 %)     MAUREL ET PROM 7.940 € (+1,99 %)     SAINT GOBAIN 74.880 € (-1,21 %)     RELX 29.220 € (+2,89 %)     WAVESTONE 38.450 € (+0,13 %)     BE SEMICONDUCTOR 247.000 € (-3,25 %)     TIKEHAU CAPITAL 17.940 € (+2,87 %)     GAUMONT 103.000 € (-7,21 %)     ADYEN 843.700 € (-0,34 %)     ICADE 18.650 € (+0,05 %)     AMG 32.000 € (0,00 %)     EXAIL TECHNOLOGIES 123.000 € (-0,73 %)     DASSAULT AVIATION 283.600 € (-1,18 %)     LEGRAND 139.250 € (-1,03 %)     VEOLIA ENVIRON. 36.950 € (+1,85 %)     SPIE 47.700 € (-0,75 %)     BROADPEAK 2.610 € (+1,95 %)     CVC CAPITAL 13.590 € (+0,74 %)     CRCAM NORM.SEINE 162.000 € (-0,31 %)     VIRBAC 324.500 € (+1,25 %)     LISI 65.800 € (+0,61 %)     DSM FIRMENICH AG 83.820 € (+0,41 %)     CRCAM SUD R.A.CCI 218.000 € (-0,91 %)     STELLANTIS NV 4.931 € (+1,85 %)     REXEL 38.860 € (+1,38 %)     BRUNEL INTERNAT 7.100 € (+2,90 %)     AYVENS 11.650 € (-2,02 %)     AKZO NOBEL 57.480 € (+0,14 %)     IMCD 86.200 € (+0,82 %)     SOCIETE GENERALE 74.640 € (+0,51 %)     ABN AMRO BANK N.V. 38.020 € (-0,03 %)     LHYFE 2.500 € (+33,12 %)  
News Réglementées
13/07/2026 15:10

iFabric Corp. Announces Launch of Aura Scrubs at U.S. National Mass Retailer

  • Third major retailer to adopt IFTNA's technology-enhanced scrub platform

  • New Brand Expands Commercial Reach of PROTX2® and ecoPEL™, the Company's Proprietary Antimicrobial and Durable Water Repellant Technologies

MARKHAM, ON / ACCESS Newswire / July 13, 2026 / iFabric Corp. ("iFabric" or the "Company") (TSX:IFA)(OTCQX:IFABF) is pleased to announce that its wholly owned subsidiary, Intelligent Fabric Technologies (North America) Inc. ("IFTNA"), is launching Aura, a new performance medical apparel scrubs line developed, branded, and manufactured by IFTNA, in cooperation with a leading U.S. national mass retailer.

The Aura scrubs collection is launching in approximately 400 brick-and-mortar stores across the United States, together with availability on the retailer's well-established e-commerce platform. The Company believes the program has the potential for expansion across additional stores, subject to consumer adoption, retail performance, and ongoing retailer planning.

Aura scrubs integrate two of IFTNA's flagship textile technologies: PROTX2®, IFTNA's advanced antimicrobial technology, and ecoPEL, IFTNA's fluorine-free durable water-repellent technology. Together, these technologies are designed to deliver enhanced performance for healthcare professionals working in demanding clinical environments.

"This launch marks another important milestone in our mission to make clinically supported textile technologies more readily accessible to healthcare professionals," said Giancarlo Beevis, President and CEO of IFTNA. "Aura brings together comfort, fit, function, and our class-leading PROTX2® and ecoPEL technologies in a product platform designed for everyday clinical use and delivered through one of the most important retail channels in the United States," added Mr. Beevis.

An IFTNA-sponsored clinical trial demonstrated statistically-significant reductions in surface bacterial contamination on treated scrubs worn in real-world healthcare environments compared with untreated scrubs, as published in the peer-reviewed Journal of Hospital Infection and available online at:

https://www.journalofhospitalinfection.com/article/S0195-6701(25)00222-1/fulltext

By integrating PROTX2® and ecoPEL into Aura scrubs, IFTNA is bringing the benefits of its clinically-validated textile platform to a broader population of healthcare professionals through additional nationwide retail distribution.

"The clinical trial results were a defining moment for IFTNA because they demonstrated that our textile technologies can deliver measurable performance in real healthcare environments," continued Mr. Beevis. "With Aura, we are now translating those results into an additional highly-accessible retail program that can reach more healthcare workers where they shop, both in stores and online," said Mr. Beevis

The launch of Aura represents the third major retailer to adopt IFTNA's technology-enhanced scrub platform and to partner with IFTNA beyond technology supply, including product development, branding, manufacturing, and retail execution. The Company believes this validates IFTNA's ability to deliver a complete end-to-end solution for major retail partners seeking differentiated, performance-driven medical apparel.

"Aura is not just another scrub launch," continued Mr. Beevis. "It reflects the full scope of what IFTNA can bring to retail partners: proprietary technologies, clinically-proven performance, product design, sourcing, manufacturing, brand development, and execution at scale. While we will let the retailer's, shelves do the talking over the coming quarters, we believe we'll hit the bullseye with this expansion," concluded Mr. Beevis

The Aura scrub assortment is expected to be available through the retailer's initial 400-store rollout and on the retailer's e-commerce platform. See link below:
https://www.target.com/b/aura/-/N-q643le6kcfe

About Aura

Aura is a new medical apparel scrubs brand developed by IFTNA to combine modern styling, comfort, fit, and utility with IFTNA's proprietary performance textile technologies. The brand is designed to provide healthcare professionals with accessible, performance-driven scrubs for everyday clinical use.

About iFabric Corp.

iFabric Corp. (TSX: IFA; OTCQX: IFABF) develops, licenses, and commercializes innovative performance technologies for textiles and apparel. Through its Intelligent Fabric Technologies (North America) division, iFabric partners with global brands and retailers to deliver enhanced fabric functionality-ranging from antimicrobial technologies to moisture management and PFAS-free water repellency-across diverse end uses. The Company also operates Coconut Grove Intimates, a long-standing intimate apparel business that provides stable cash flow and supports the continued growth of its technology platform.

For more information, visit:

www.ifabriccorp.com.

About IFTNA

Intelligent Fabric Technologies (North America) Inc., a wholly owned subsidiary of iFabric Corp., engineers and supplies proprietary textile chemistries-including PROTX2®, ecoPEL™, and DryTX™-and provides end-to-end program capabilities spanning technology integration, product development, branding support, and manufacturing execution across consumer, medical, and industrial markets.

About PROTX2®

PROTX2® is an eco-friendly textile technology designed to provide antimicrobial and anti-odour protection. When applied, PROTX2® is engineered to deliver durable performance intended to last through the life of the garment.

About ecoPEL™

ecoPEL™ is a fluorine-free durable water repellent ("DWR") technology designed to help deliver water repellency while maintaining fabric comfort and breathability, and to support sustainability objectives by avoiding fluorinated chemistry.

Forward-Looking Statements

This news release contains forward-looking statements within the meaning of applicable securities laws, including statements regarding the scope and timing of the Aura launch, potential store expansion, market adoption, future distribution, anticipated product performance attributes, prospective sales results, and the Company's retail growth strategy. Forward-looking statements are based on current expectations and are subject to risks and uncertainties that could cause actual results to differ materially. iFabric undertakes no obligation to update forward-looking statements except as required by applicable law.

FOR FURTHER INFORMATION PLEASE CONTACT:

Hylton Karon, President & CEO
Tel: 647.297.9815
Email: hyltonk@ifabriccorp.com

Giancarlo Beevis, COO
Tel: 647.225.4426
Email: gc@ifabriccorp.com

Hilton Price, CFO
Tel: 647.465.6161
Email: hilton.price@rogers.com

Website: www.ifabriccorp.com

Neither the TSX Exchange nor its Regulation Services Provider, as that term is defined in the policies of the TSX Exchange, accepts responsibility for the adequacy or accuracy of this press release.

SOURCE: iFabric Corp



View the original press release on ACCESS Newswire

Source : Webdisclosure.com

© 2026 Tous droits réservés
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière